Oncologix Tech Inc. Receivables Turnover Ratio (OCLG), from the third quarter 2015 to the third quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Oncologix Tech Inc.  (OCLG)
 

Oncologix Tech Accounts Receivables Turnover Ratio from the third quarter 2015 to the third quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Oncologix Tech Inc.'s ability to collect accounts receivable sequentially worsen to 6.15, indicating more challenging environment then in the second quarter 2015, but still, it is a far cry from any concerns. Oncologix Tech's Accounts Receivable average collection period in the May 31 2015 quarter, has increased to 59 days, from 46 days, in the Feb 28 2015 quarter.

If we take a look into Healthcare sector 49 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 812, from overall ranking in the second quarter 2015 at 2422.

What is Receivable Turnover Ratio?
What is Oncologix Tech Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCLG Receivables Turnover Ratio (May 31 2015)
III. Quarter		 (Feb 28 2015)
II. Quarter		 (Nov 30 2014)
I. Quarter		 (Aug 31 2014)
IV. Quarter		 (May 31 2014)
III. Quarter
Y / Y Receivable Change 342.92 % 260.46 % 555.05 % 97.01 % 6102.17 %
Y / Y Revenue Change 25.02 % 24.81 % 60.34 % 355.61 % 3308.46 %
Receivable Turnover Ratio (TTM) 6.15 7.94 10.71 17.77 16.12
OCLG's Total Ranking # 812 # 2422 # 2422 # 2271 # 2279
Accounts Receivable average collection period days 59 46 34 21 23
Seq. Receivable Change 13.92 % 8.76 % 292.24 % -8.86 % -7.29 %
Seq. Revenue Change 0.63 % 5.68 % 18.47 % -0.78 % 0.47 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 50
Overall Market # 812

Receivable Turnover Ratio Statistics
High Average Low
1.65 1.41 1.02
(Aug 31 2014)   (Feb 28 2014)





OCLG Company Profile • Back to OCLG Efficiency Comparisons • Compare OCLG Receivables Turnover Ratio to its Competitors

Financial Statements
Oncologix Tech's Accounts Receivable $ 1 Millions Visit OCLG's Balance sheet
Oncologix Tech's Sales TTM $ 5 Millions Visit OCLG's Income Statement
Sources of OCLG's Revenues Visit OCLG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OCLG's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OCLG's Growth Rates OCLG's Roa OCLG's Inventory Turnover Ratio OCLG's Dividend Comparisons
OCLG's Profitability Ratios OCLG's Roi OCLG's Asset Turnover Ratio OCLG's Dividend Growth
OCLG's Valuation Ratios OCLG's Roe OCLG's Financial Strength Ratios OCLG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending May 31 2015 Receivable at quarter ending May 31 2015
Alaunos Therapeutics Inc   12.04 $ 1.517  Millions$ 0.126  Millions
Immucell Corporation  11.82 $ 9.037  Millions$ 0.765  Millions
Livanova Plc  11.68 $ 300.565  Millions$ 25.744  Millions
Regeneron Pharmaceuticals Inc   11.54 $ 3,396.346  Millions$ 294.330  Millions
Amedisys Inc  11.50 $ 1,216.533  Millions$ 105.822  Millions
Chemed Corporation  11.47 $ 1,496.373  Millions$ 130.455  Millions
Assertio Holdings inc   11.46 $ 372.793  Millions$ 32.542  Millions
Magellan Health inc   11.40 $ 4,044.204  Millions$ 354.782  Millions
Lifeloc Technologies Inc   11.20 $ 9.248  Millions$ 0.825  Millions
First Choice Healthcare Solutions Inc   11.16 $ 31.346  Millions$ 2.809  Millions
Intelgenx Technologies Corp   11.12 $ 2.487  Millions$ 0.224  Millions
Surmodics Inc   10.89 $ 59.870  Millions$ 5.497  Millions
Encision Inc   10.68 $ 9.818  Millions$ 0.920  Millions
Lifemd Inc   10.66 $ 0.891  Millions$ 0.084  Millions
Cti Biopharma Corp   10.63 $ 61.151  Millions$ 5.754  Millions
Cba Florida Inc   10.57 $ 4.071  Millions$ 0.385  Millions
Vystar Corporation  10.11 $ 0.487  Millions$ 0.048  Millions
Corcept Therapeutics Inc  10.01 $ 38.353  Millions$ 3.833  Millions
Amphastar Pharmaceuticals Inc   9.95 $ 226.327  Millions$ 22.735  Millions
Allied Healthcare Products inc   9.95 $ 35.462  Millions$ 3.566  Millions
Dyne Therapeutics Inc   9.86 $ 3,075.000  Millions$ 311.750  Millions
Dyax Corp  9.75 $ 94.812  Millions$ 9.725  Millions
Biocryst Pharmaceuticals Inc   9.74 $ 41.352  Millions$ 4.244  Millions
Biodelivery Sciences International Inc   9.70 $ 19.156  Millions$ 1.976  Millions
Panbela Therapeutics Inc   9.45 $ 1.383  Millions$ 0.146  Millions
Ontrak Inc   9.44 $ 2.405  Millions$ 0.255  Millions
Dynatronics Corporation  9.42 $ 29.118  Millions$ 3.090  Millions
Regulus Therapeutics Inc   9.28 $ 13.336  Millions$ 1.437  Millions
Akebia Therapeutics Inc   9.25 $ 0.525  Millions$ 0.057  Millions
Igc Pharma Inc   9.24 $ 8.775  Millions$ 0.950  Millions

Date modified: 2026-08-29T17:14:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.